По вашему запросу найдено документов: 583

Страница 1 из 59

A RANDOMIZED PHASE 2 STUDY OF LONG-ACTING TRANSCON GH VS DAILY GH IN CHILDHOOD GH DEFICIENCY
Chatelain, Pierre, Malievskiy, Oleg, Radziuk, Klaudziya, Senatorova, Ganna, Abdou, Magdy O., Vlachopapadopoulou, Elpis, Skorodok, Yulia, Peterkova, Valentina, Leff, Jonathan A., Beckert, Michael (2017)
Context: TransCon Growth Hormone (GH) (Ascendis Pharma) is a long-acting recombinant sustained
LONG-ACTING C-TERMINAL PEPTIDE-MODIFIED HGH (MOD-4023): RESULTS OF A SAFETY AND DOSE-FINDING STUDY IN GHD CHILDREN
Zelinska, N., Iotova, V., Skorodok, J., Malievsky, O., Peterkova, V., Samsonova, L., Rosenfeld, Ron G., Zadik, Zvi, Jaron-Mendelson, Michal, Koren, Ronit, Amitzi, Leanne, Raduk, Dmitri, Hershkovitz, Oren, Hart, Gili (2017)
LONG-ACTING C-TERMINAL PEPTIDE-MODIFIED HGH (MOD-4023): RESULTS OF A SAFETY AND DOSE-FINDING STUDY
Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results
Maniatis, AK;, Casella, SJ;, Nadgir, UM;, Hofman, PL;, Saenger, P;, Chertock, ED;, Aghajanova, EM;, Korpal-Szczyrska, M;, Vlachopapadopoulou, E;, Malievskiy, O;, Chaychenko, T;, Cappa, M;, Song, WJ;, Mao, M;, Mygind, PH;, Smith, AR;, Chessler, S;, Komirenko, AS;, Beckert, M;, Aimee, D Shu, Paul, S Thornton (2022)
the long-term safety and efficacy of weekly administered long-acting growth hormone lonapegsomatropin
An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
Zadik, Zvi, Zelinska, Nataliya, Iotova, Violeta, Skorodok, Yulia, Malievsky, Oleg, Mauras, Nelly, Valluri, Srinivas Rao, Pastrak, Aleksandra, Rosenfeld, Ron (2023)
Objectives: Somatrogon is a long-acting recombinant human growth hormone (GH) employed as a once
Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study
Deal, C, Steelman, J, Vlachopapadopoulou, E, Stawerska, R, Silverman, LA;, Phillip, M, Kim, HS, Ko, CW, Malievskiy, O, Cara, JF, Roland, CL, Taylor, CT, Valluri, SR, Wajnrajch, MP, Pastrak, A, Miller, BS (2022)
Context: Somatrogon is a long-acting recombinant human growth hormone (rhGH) in development
Children with Growth Hormone Deficiency Treated with Lonapegsomatropin Demonstrated Sustained Height Improvements for up to 6 Years: enliGHten Trial Final Results
Maniatis, Aristides K., Thornton, Paul S., Nadgir, Ulhas M., Vlachopapadopoulou, Elpis, Malievskiy, Oleg, Aghajanova, Elena M., Korpal-Szczyrska, Maria, Woods, Katie A., Mao, Meng, Zhao, Carol, Abdelrahman, Sohair G., Huang, Eric A., Komirenko, Allison S., Shu, Aimee D., Shu, A.D., Hofman, Paul (2025)
Introduction: This international, Phase 3, open-label extension trial evaluated the long
EFFICACY OF ONCE-WEEKLY ADMINISTRATION OF CTP-MODIFIED HUMAN GROWTH HORMONE (MOD-4023): 24-MONTH COMPLETE DATABASE RESULTS OF A PHASE 2 STUDY IN CHILDREN WITH GROWTH HORMONE DEFICIENCY
Zelinska, N., Skorodok, J., Skorodok, J., Malievsky, O., Rosenfeld, R.G., Zadik, Z., Koren, R., Vander, S., Hart, G., Raduk, D. (2016)
OPKO Biologics is developing bio-better long-acting versions of existing therapeutic proteins
КЛИНИКO-ИММУНОЛОГИЧЕСКОЕ ОБОСНОВАНИЕ ПРИМЕНЕНИЯ СТОМАТОЛОГИЧЕСКОЙ МАЗИ, РАЗРАБОТАННОЙ НА ОСНОВЕ ПРОДУКТА ПЧЕЛОВОДСТВА ДЛЯ ЛЕЧЕНИЯ ВОСПАЛИТЕЛЬНЫХ ЗАБОЛЕВАНИЙ ПАРОДОНТА
CLINICO-IMMUNOLOGICAL JUSTIFICATION OF THE USE OF A NEW DENTAL OINTMENT DEVELOPED ON THE BASIS OF A LONG-ACTING BEEKEEPING PRODUCT FOR TOPICAL TREATMENT OF INFLAMMATORY PARODONTAL DISEASES
БУЛГАКОВА, А.И., ВАСИЛЬЕВА, Н.А., ШИКОВА, Ю.В., ИМЕЛЬБАЕВА, Э.А., АХМАДЕЕВА, Ф.Р., BULGAKOVA, A.I., VASILIEVA, N.A., SHIKOVA, Y.V., IMELBAYEVA, E.A., AHMADEEVA, F.R. (2019)
LONG-ACTING BEEKEEPING PRODUCT FOR TOPICAL TREATMENT OF INFLAMMATORY PARODONTAL DISEASES
MiRNAs and lncRNAs in the regulation of innate immune signaling
Gareev, Ilgiz, de Jesus Encarnacion Ramirez, Manuel, Goncharov, Evgeniy, Ivliev, Denis, Shumadalova, Alina, Ilyasova, Tatiana, Wang, Chunlei (2023)
have identified microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as key players in controlling
The role of lncRNA-mediated ceRNA regulatory networks in liver fibrosis
Jiang, Jianhao, Gareev, Ilgiz, Ilyasova, Tatiana, Shumadalova, Alina, Du, Weijie, Yang, Baofeng (2024)
In the dynamic realm of molecular biology and biomedical research, the significance of long non

Страница 1 из 59

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год